IDEXX Laboratories, Inc. (IDXX) has a MoatMap StockRank of 53/100 based on Quality (77/100), Value (19/100), and Momentum (42/100) factor scores. The current signal is HOLD. IDEXX is an exceptional quality compounder with a massive competitive moat in veterinary diagnostics, high recurring revenues, and stellar ROIC. However, it lacks a direct link to our active 18-month macro themes, making it a lower priority for immediate capital allocation under the Druckenmiller lens.
IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics and water quality testing, developing and manufacturing proprietary products and services for companion animals, livestock, and poultry. The company benefits from a substantial installed base of diagnostic instruments in veterinary practices, generating high-margin recurring revenue from consumables and reference laboratory services. Its strong market position is reinforced by high switching costs and continuous innovation in pet healthcare technology.
| Price | $563.53 |
| Market Cap | $44.8B |
| P/E (TTM) | 41.49 |
| P/E (Forward) | 34.19 |
| Price/Book | 28.76 |
| Return on Equity | 72.9% |
| Return on Invested Capital | 61.9% |
| Debt/Equity | 71.04 |
| Gross Margin | 62.1% |
| Operating Margin | 31.8% |
| Revenue Growth | 14.3% |
| Free Cash Flow | $787M |
IDEXX Laboratories, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).